What Is Mounjaro and How Does It Differ from Other GLP-1 Medications?
Mounjaro (tirzepatide) is a once-weekly injectable prescription medication manufactured by Eli Lilly that is approved for the treatment of type 2 diabetes. What makes Mounjaro unique among diabetes medications is its dual mechanism of action: it is the first drug to activate both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual-agonist approach has demonstrated superior blood sugar control and weight loss compared to GLP-1-only medications like Ozempic in head-to-head clinical trials.
In the landmark SURPASS clinical trial program, Mounjaro at its highest dose reduced hemoglobin A1c by an average of 2.0 to 2.4 percentage points and produced average weight loss of approximately 12 to 25 percent of body weight, results that exceeded those achieved by any previously approved diabetes medication. These impressive results have generated enormous demand for Mounjaro, making it one of the fastest-growing prescription medications in the United States.
However, the outstanding clinical performance of Mounjaro comes with a significant price tag. Understanding the costs, insurance coverage landscape, and available savings programs is essential for patients considering or currently using this medication. This comprehensive guide breaks down everything you need to know about Mounjaro costs in 2026.
Mounjaro Retail Pricing in 2026
The list price of Mounjaro in 2026 is approximately 1,000 to 1,200 dollars for a carton of four single-dose pens providing a one-month supply. Retail cash prices vary by pharmacy and dose, with typical prices of approximately 1,050 to 1,150 dollars at CVS, 1,030 to 1,130 dollars at Walgreens, 1,000 to 1,100 dollars at Walmart, and 980 to 1,080 dollars at Costco. Mounjaro is available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, with the starting dose of 2.5 mg gradually titrated upward based on response and tolerability.
Insurance Coverage for Mounjaro
Commercial Insurance
As an FDA-approved medication for type 2 diabetes, Mounjaro is covered by the majority of commercial health insurance plans. However, coverage terms vary significantly between plans. Most plans require prior authorization, which involves documenting the diagnosis of type 2 diabetes and often demonstrating that the patient has tried metformin or other first-line therapies. Mounjaro is typically placed on a specialty or non-preferred brand formulary tier, with copays ranging from 25 to 150 dollars per month on preferred tiers and 100 to 300 dollars or coinsurance of 25 to 50 percent on non-preferred tiers.
Insurance coverage for Mounjaro when prescribed off-label for weight loss in patients without diabetes is much more limited. While some commercial plans may cover off-label use with appropriate documentation, many plans specifically exclude coverage for medications used primarily for weight management. If weight loss is the primary goal, discuss with your doctor whether Zepbound (tirzepatide marketed specifically for weight loss) or Wegovy might be covered under your plan weight management benefit.
Medicare Part D
Medicare Part D plans cover Mounjaro for the treatment of type 2 diabetes. Coverage is subject to formulary placement, prior authorization requirements, and the plan specific cost-sharing structure. Under the 2025 Medicare Part D redesign, annual out-of-pocket costs are capped at 2,000 dollars, which provides meaningful protection for patients taking expensive medications like Mounjaro. The Medicare Prescription Payment Plan also allows beneficiaries to spread their out-of-pocket costs evenly across the calendar year rather than paying large amounts during the deductible and coverage gap phases.
Medicaid Coverage
Most state Medicaid programs cover Mounjaro for type 2 diabetes, though coverage terms including prior authorization requirements and preferred alternatives vary by state. Medicaid patients typically pay minimal or no copays for covered medications. Contact your state Medicaid program or managed care plan to verify coverage and understand any requirements that must be met before Mounjaro can be dispensed.
Eli Lilly Savings Programs
Eli Lilly offers the Mounjaro Savings Card for commercially insured patients, which can reduce monthly copays to as low as 25 dollars. The savings card covers the difference between your insurance copay and the reduced amount, with a maximum monthly and annual benefit limit. This program is available to patients with commercial insurance that covers Mounjaro and cannot be used with Medicare, Medicaid, or other government-funded insurance programs.
The Lilly Cares Patient Assistance Program provides Mounjaro at no cost to eligible patients who are uninsured, have limited income, and meet specific financial criteria. Application requires documentation of income, insurance status, and a valid prescription from a healthcare provider. Processing times vary, and patients may need to use other savings strategies while their application is being reviewed.
Discount Card Pricing for Mounjaro
Prescription discount cards offer modest savings on Mounjaro for patients paying cash. GoodRx typically shows prices of 850 to 1,000 dollars per month, SingleCare shows similar pricing of 870 to 1,020 dollars, and RxSaver may show slightly different prices depending on the pharmacy. These discounts of approximately 10 to 20 percent off retail are helpful but still leave the medication expensive for out-of-pocket payers. Comparing prices across multiple discount platforms and pharmacies is recommended to find the lowest available price for each fill.
Mounjaro vs Ozempic: Cost Comparison
Mounjaro and Ozempic are similarly priced, with both medications costing approximately 900 to 1,200 dollars per month at retail. Insurance copays are also similar, though the specific amount depends on each plan formulary placement of the two drugs. Some insurance plans may have a preferred status for one medication over the other, resulting in lower copays. From a clinical perspective, Mounjaro has demonstrated superior A1c reduction and weight loss compared to Ozempic in head-to-head trials, which may factor into the value assessment for patients deciding between the two medications.
Tips for Reducing Mounjaro Costs
To minimize your Mounjaro costs, start by confirming insurance coverage and completing any required prior authorization before filling your first prescription. Apply for the Eli Lilly Savings Card if you have commercial insurance. Compare prices at multiple pharmacies using GoodRx and SingleCare. Ask your doctor about the most cost-effective dosing strategy, as the clinical benefits may be achieved at lower doses for some patients. Explore the Lilly Cares Patient Assistance Program if you are uninsured or underinsured. Consider using a mail-order pharmacy, which may offer slight savings on specialty medications. Stay informed about potential biosimilar or generic versions of tirzepatide, which may become available as patents expire.
The Long-Term Value Perspective
While the monthly cost of Mounjaro is significant, the medication exceptional clinical efficacy can provide substantial long-term health and economic benefits. Effective blood sugar control reduces the risk of diabetic complications including retinopathy, neuropathy, nephropathy, and cardiovascular disease, all of which carry enormous treatment costs. The significant weight loss associated with Mounjaro can also reduce the need for other medications, improve quality of life, and decrease the risk of weight-related health conditions. Discuss with your doctor and insurance provider the full range of benefits and costs to make an informed treatment decision.